Missense mutations in the amyloid precursor protein (APP) and presenilin genes can lead to an increase in the production of the amyloid-beta (Aβ) peptide, which can predispose to the development of AD-type brain pathology [65–69]. Here, APP is linked to Alzheimer disease.